In addition to the aforementioned studies, a meta-analysis has revealed a significant association between elevated concentrations of certain inflammatory mediators, including IL-1β, IL-6, TNF-α, and ICAM-1, and an inclined risk of NAFLD (Duan et al., 2022). This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.